FDA approves new breast implants by Allergan, requires post-approval studies

February 20, 2013 by Arezu Sarvestani

Aesthetic products maker Allergan lands FDA approval for a new silicon gel-filled breast implant, on the condition that the company conduct post-approval studies to keep an eye on the long-term safety and effectiveness of the device.

breast exam image

Aesthetic medical device giant Allergan (NYSE:AGN) won FDA approval this week for a new generation of its Natrelle silicon gel-filled breast implants.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp